HLA-DR/DQ eplet mismatch predicts de novo donor-specific antibody development in multi-ethnic Southeast Asian kidney transplant recipients on different immunosuppression regimens

被引:1
|
作者
Wong, Emmett Tsz Yeung [1 ,2 ,3 ]
Pochinco, Denise [4 ]
Vathsala, Anantharaman [1 ,2 ]
Koh, Wee Kun [2 ]
Lim, Amy [2 ]
Sran, Hersharan Kaur [1 ,2 ]
D'Costa, Matthew Ross [2 ]
Chang, Zi Yun [2 ]
Nickerson, Peter W. [3 ,4 ,5 ]
Wiebe, Chris [3 ,4 ,5 ]
机构
[1] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore
[2] Natl Univ Singapore Hosp, Natl Univ Ctr Organ Transplantat, Singapore, Singapore
[3] Univ Manitoba, Dept Med, Winnipeg, MB, Canada
[4] Shared Hlth Serv Manitoba, Winnipeg, MB, Canada
[5] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada
关键词
human leukocyte antigen; histocompatibility; molecular mismatch; eplets; kidney transplant; donor-specific antibodies; MEDIATED REJECTION; EPITOPE-MISMATCH; FAILURE; RISK;
D O I
10.3389/fgene.2024.1447141
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Eplet mismatch has been recognized as a more precise strategy for determining HLA compatibility by analyzing donor-recipient HLA differences at the molecular level. However, predicting post-transplant alloimmunity using single-molecule eplet mismatch categories has not been validated in Asian cohorts. We examined a cohort of Southeast Asian kidney transplant recipients (n = 234) to evaluate HLA-DR/DQ eplet mismatch as a predictor of de novo donor-specific antibody (dnDSA) development. HLA-DR/DQ single-molecule eplet mismatch was quantified using HLA Matchmaker, and we utilized previously published HLA-DR/DQ eplet mismatch thresholds to categorize recipients into alloimmune risk groups and evaluate their association with dnDSA development. Recognizing that the predominance of cyclosporine use (71%) may alter published eplet mismatch thresholds derived from a largely tacrolimus-based (87%) cohort, we evaluated cohort-specific thresholds for HLA-DR/DQ single-molecule eplet mismatch categories. Recipient ethnicities included Chinese (65%), Malays (17%), Indians (14%), and others (4%). HLA-DR/DQ dnDSA developed in 29/234 (12%) recipients after a median follow-up of 5.4 years, including against isolated HLA-DR (n = 7), isolated HLA-DQ (n = 11), or both (n = 11). HLA-DR/DQ single-molecule eplet mismatch risk categories correlated with dnDSA-free survival (p = 0.001) with low-risk recipients having a dnDSA prevalence of 1% over 5 years. The cohort-specific alloimmune risk categories improved correlation with HLA-DR/DQ dnDSA-free survival and remained significant after adjusting for calcineurin inhibitor and anti-metabolite immunosuppression (p < 0.001). We validated the performance of single-molecule eplet mismatch categories as a prognostic biomarker for HLA-DR/DQ dnDSA development in a cohort of predominantly Asian kidney transplant recipients after adjusting for different immunosuppression regimens.
引用
收藏
页数:9
相关论文
共 43 条
  • [31] Mismatched Eplets in HLA Antigens May Predict Development of De Novo Donor Specific Antibody (dnDSA) in Kidney Transplant Recipients
    Verbesey, J.
    Timofeeva, O.
    Li, D.
    Javaid, B.
    Grafals, M.
    Gilbert, A.
    Rosen-Bronson, S.
    Cooper, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 513 - 513
  • [32] De Novo Donor-Specific HLA Antibody Development and Peripheral CD4(+)CD25(high) Cells in Kidney Transplant Recipients: A Place for Interaction?
    Alberu, Josefina
    Ines Vargas-Rojas, Maria
    Morales-Buenrostro, Luis E.
    Crispin, Jose C.
    Rodriguez-Romo, Roxana
    Uribe-Uribe, Norma O.
    Carrasco, Gabriel
    Gomez-Martin, Diana
    Alcocer-Varela, Jorge
    JOURNAL OF TRANSPLANTATION, 2012, 2012
  • [33] HLA-DQ eplet mismatch load may identify kidney transplant patients eligible for tacrolimus withdrawal without donor-specific antibody formation after mesenchymal stromal cell therapy
    Bezstarosti, Suzanne
    Meziyerh, Soufian
    Reinders, Marlies E. J.
    Voogt-Bakker, Kim
    Groeneweg, Koen E. E.
    Roelen, Dave L. L.
    Kers, Jesper
    de Fijter, Johan W. W.
    Heidt, Sebastiaan
    HLA, 2023, 102 (01) : 3 - 12
  • [34] Mismatched Eplets in HLA Antigens May Predict Development of De Novo Donor Specific Antibody (dnDSA) in Kidney Transplant Recipients.
    Verbesey, J.
    Timofeeva, O.
    Li, D.
    Javaid, B.
    Grafals, M.
    Gilbert, A.
    Rosen-Bronson, S.
    Cooper, M.
    TRANSPLANTATION, 2014, 98 : 513 - 513
  • [35] HLA-DR/DQ molecular mismatches for risk stratification fi cation and prediction of development of de novo donor-specific fi c antibodies in cardiac allogeneic transplantation
    Misra, M. K.
    Marino, S. G.
    HUMAN IMMUNOLOGY, 2024, 85
  • [36] HLA EPITOPE-MISMATCH MORE PRECISELY PREDICTS THE DEVELOPMENT OF DE NOVO DONOR SPECIFIC ANTIBODY AND ACUTE CELLULAR REJECTION AFTER LUNG TRANSPLANT
    Zhang, Aiwen
    Stopczynski, Nathan
    Thomas, Dawn
    Sun, Yuchu
    McMichael, John
    Kawczak, Paul
    Allen, Jeffrey
    Budev, Marie
    Bray, Robert A.
    Gebel, Howard
    HUMAN IMMUNOLOGY, 2018, 79 : 21 - 22
  • [37] Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients
    Lee, Hyeyoung
    Han, Eunhee
    Choi, Ae-Ran
    Ban, Tae Hyun
    Chung, Byung Ha
    Yang, Chul Woo
    Choi, Yeong Jin
    Oh, Eun-Jee
    PLOS ONE, 2018, 13 (11):
  • [38] Impact of low tacrolimus exposure and high tacrolimus intra-patient variability on the development of de novo anti-HLA donor-specific antibodies in kidney transplant recipients
    Rojas, Aleixandra Mendoza
    Hesselink, Dennis A.
    van Besouw, Nicole M.
    Baan, Carla C.
    van Gelder, Teun
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2019, 15 (12) : 1323 - 1331
  • [39] Single fixed low-dose rituximab as induction therapy suppresses de novo donor-specific anti-HLA antibody production in ABO compatible living kidney transplant recipients
    Tomita, Yusuke
    Iwadoh, Kazuhiro
    Ogawa, Yuichi
    Miki, Katsuyuki
    Kato, Yojiro
    Kai, Kotaro
    Sannomiya, Akihito
    Koyama, Ichiro
    Kitajima, Kumiko
    Nakajima, Ichiro
    Fuchinoue, Shohei
    PLOS ONE, 2019, 14 (10):
  • [40] Effect of blood transfusion post kidney transplantation on de novo human leukocytes antigen donor-specific antibody development and clinical outcomes in kidney transplant recipients: A systematic review and meta-analysis
    Kang, Zhong-Yu
    Ma, Shuangshuang
    Liu, Wei
    Liu, Chun
    TRANSPLANT IMMUNOLOGY, 2023, 78